COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 533
[43] Genuis SJ. Elimination of persistent toxicants from the human
body. Hum Exp Toxicol. 2011;30(1):3-18.
[44] Sears ME, Genuis SJ. Environmental determinants of chronic
disease and medical approaches: recognition, avoidance,
supportive therapy, and detoxification. J Environ Public Health.
2012;2012:356798.
[45] Miller CS. The compelling anomaly of chemical intolerance.
Ann N Y Acad Sci. 2001;933:1-23.
[46] Crinnion WJ. The CDC fourth national report on human
exposure to environmental chemicals: what it tells us about our
toxic burden and how it assists environmental medicine physicians.
Altern Med Rev. 2010;15(2):101-109.
[47] Minich DM, Brown BI. A review of dietary (phyto)nutrients for
glutathione support. Nutrients. 2019;11(9):2073.
[48] Vojdani A, Lambert J. The role of Th17 in neuroimmune
disorders: target for CAM therapy. Part I. Evid Based Complement
Alternat Med. 2011;2011:927294.
[49] Genuis SJ. Sensitivity-related illness: the escalating pandemic
of allergy, food intolerance and chemical sensitivity. Sci Total
Environ. 2010;408(24):6047-6061.
[50] Vojdani A, Vojdani E, Cooper E. Antibodies to myelin basic
protein, myelin oligodendrocytes peptides, ³-´-crystallin,
lymphocyte activation and cytokine production in patients with
multiple sclerosis. J Intern Med. 2003;254(4):363-374.
[51] Fasano A. Zonulin and its regulation of intestinal barrier
function: the biological door to inflammation, autoimmunity, and
cancer. Physiol Rev. 2011;91(1):151-175.
[52] Vojdani A, Kharrazian D. The usefulness of anti-tissue antibody
testing for predicting autoimmune diseases. Autoimmune Dis.
2014;2014:167478.
533
